1. Home
  2. NCTY vs STIM Comparison

NCTY vs STIM Comparison

Compare NCTY & STIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo The9 Limited American Depository Shares

NCTY

The9 Limited American Depository Shares

HOLD

Current Price

$6.96

Market Cap

97.7M

ML Signal

HOLD

Logo Neuronetics Inc.

STIM

Neuronetics Inc.

HOLD

Current Price

$1.91

Market Cap

105.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NCTY
STIM
Founded
1999
2003
Country
China
United States
Employees
N/A
N/A
Industry
Business Services
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
97.7M
105.5M
IPO Year
2004
2018

Fundamental Metrics

Financial Performance
Metric
NCTY
STIM
Price
$6.96
$1.91
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$7.00
AVG Volume (30 Days)
35.2K
1.4M
Earning Date
03-27-2015
03-03-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$11,403,864.00
$129,873,000.00
Revenue This Year
N/A
$101.67
Revenue Next Year
N/A
$10.87
P/E Ratio
N/A
N/A
Revenue Growth
N/A
78.61
52 Week Low
$5.95
$1.25
52 Week High
$17.83
$5.92

Technical Indicators

Market Signals
Indicator
NCTY
STIM
Relative Strength Index (RSI) 48.28 58.40
Support Level $6.40 $1.73
Resistance Level $7.16 $2.13
Average True Range (ATR) 0.48 0.19
MACD 0.03 0.04
Stochastic Oscillator 55.22 72.83

Price Performance

Historical Comparison
NCTY
STIM

About NCTY The9 Limited American Depository Shares

The9 Ltd operates a cryptocurrency mining business. It provides computing power, or hash rate, to a Bitcoin mining pool and is entitled to receive a fractional share of Bitcoin award from the Bitcoin mining pool in return. The company generates its revenues from customers in Greater China, Asia/Eastern Europe, and North America. Its segments are: Crypto mining business, and Other, out of which Crypto mining business derives maximum revenue.

About STIM Neuronetics Inc.

Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulations, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.

Share on Social Networks: